Immunothrombosis: a COVID-19 concerto
- PMID: 34114208
- DOI: 10.1111/bjh.17666
Immunothrombosis: a COVID-19 concerto
Comment on
-
COVID-19 and immunothrombosis: emerging understanding and clinical management.Br J Haematol. 2021 Aug;194(3):518-529. doi: 10.1111/bjh.17664. Epub 2021 Jul 7. Br J Haematol. 2021. PMID: 34114204 Review.
References
-
- Ackermann M, Verleden SE, Kuehnel M, Haverich A, Welte T, Laenger F, et al. Pulmonary vascular endothelialitis, thrombosis, and angiogenesis in Covid-19. N Engl J Med. 2020;383:120-8.
-
- Hottz ED, Azevedo-Quintanilha IG, Palhinha L, Teixeira L, Barreto EA, Pão CR, et al. Platelet activation and platelet-monocyte aggregate formation trigger tissue factor expression in patients with severe COVID-19. Blood. 2020;136:1330-41.
-
- Middleton E, Cody M, Rondina M. Neutrophil extracellular traps (NETs) contribute to immunothrombosis in COVID-19 acute respiratory distress syndrome clinical trial registration information (if any). Blood. 2020;136:1169-79.
-
- Goshua G, Pine AB, Meizlish ML, Chang CH, Zhang H, Bahel P, et al. Endotheliopathy in COVID-19-associated coagulopathy: evidence from a single-centre, cross-sectional study. Lancet Haematol. 2020;7:e575-e582.
-
- Magro C, Mulvey JJ, Berlin D, Nuovo G, Salvatore S, Harp J, et al. Complement associated microvascular injury and thrombosis in the pathogenesis of severe COVID-19 infection: a report of five cases. Transl Res. 2020;220:1-13.
Publication types
MeSH terms
LinkOut - more resources
Medical